SAPPORO CLINICAL LABORATORY INC.

Other languages Sapporo Clinical Laboratory Inc.

Equities

9776

JP3321100004

Delayed Japan Exchange Other stock markets 09:11:47 2024-07-17 pm EDT			5-day change	1st Jan Change
1,012 ^JPY	+0.40%		+0.30%	+1.10%

Mar. 27	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.	CI
Mar. 26	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million.	Feb. 26
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	Feb. 25
Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million.	22-05-30
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	22-05-29
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million.	22-02-28
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.	22-02-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer